•
Dec 31, 2021

Bruker Q4 2021 Earnings Report

Bruker's Q4 2021 financial results were reported, showing revenue growth and EPS increase.

Key Takeaways

Bruker reported Q4 2021 revenues of $683.5 million, an 8.9% increase year-over-year, with organic revenue growth of 11.4%. GAAP EPS was $0.50, and non-GAAP EPS was $0.59, up $0.01 year-over-year. The company anticipates solid organic revenue and non-GAAP EPS growth in FY 2022.

Q4 2021 revenues reached $683.5M, reflecting an 8.9% year-over-year increase.

Organic revenue growth for Q4 2021 was 11.4% year-over-year.

Q4 2021 GAAP EPS stood at $0.50, while non-GAAP EPS reached $0.59, a $0.01 increase year-over-year.

Bruker anticipates robust organic revenue and non-GAAP EPS growth in FY 2022, driven by investments in Project Accelerate 2.0 initiatives.

Total Revenue
$684M
Previous year: $628M
+8.9%
EPS
$0.59
Previous year: $0.58
+1.7%
Organic Revenue Growth
11.4%
Previous year: -0.4%
-2950.0%
Non-GAAP Operating Margin
21%
Previous year: 22.5%
-6.7%
Gross Profit
$342M
Previous year: $313M
+9.1%
Cash and Equivalents
$1.07B
Previous year: $682M
+56.7%
Free Cash Flow
$110M
Previous year: $174M
-36.7%
Total Assets
$3.65B
Previous year: $3.05B
+19.7%

Bruker

Bruker

Forward Guidance

Bruker expects approximately 5% to 7% year-over-year revenue growth, including organic revenue growth of approximately 6% to 8%, M&A contribution of approximately 1%, and foreign currency translation headwind of approximately -2%. In FY 2022, Bruker expects non-GAAP operating margin expansion of 30 bps to 60 bps year-over-year, from 19.4% in FY 2021. Finally, Bruker expects FY 2022 non-GAAP EPS of $2.29 to $2.33, a 9% to 11% increase year-over-year.

Positive Outlook

  • Approximately 5% to 7% year-over-year revenue growth is expected.
  • Organic revenue growth of approximately 6% to 8% is anticipated.
  • M&A is expected to contribute approximately 1%.
  • Non-GAAP operating margin expansion of 30 bps to 60 bps year-over-year is projected.
  • FY 2022 non-GAAP EPS is expected to be $2.29 to $2.33, a 9% to 11% increase year-over-year.

Challenges Ahead

  • Foreign currency translation headwind of approximately -2% is expected.
  • Supply chain and inflation challenges will likely persist through H1 2022.
  • First-half operating margins are expected to be about 500-600 bps lower than second-half operating margins.
  • R&D investments are planned to be approximately 10% of revenue during FY 2022.
  • Unable to predict with reasonable certainty certain items that may affect such measures calculated and presented in accordance with GAAP without unreasonable effort.